NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 11/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 11/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 11/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 11/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 11/12/21 | 8-K | Current report filing |
|
22 | |
| 11/12/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
172 | |
| 11/12/21 | CERT | Certification by an exchange approving securities for listing |
|
1 | |
| 11/12/21 | 8-A12B | Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) |
|
2 | |
| 11/10/21 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 |